The Siren Song of 'Secret' Serums: Why Influencer-Pushed Peptides Could Be Perilous

The Market's Whispers: Unpacking Today's Corporate Buzz

A New Chapter for Little Stomachs: Ironwood's Linzess Opens Doors for Pediatric IBS Relief

A Breath of Fresh Air for Kids Living with IBS-C

The Zynity Enigma: When Innovation Meets Intense Scrutiny at the FDA

The High Stakes Game: Sarepta, Duchenne, and the Edge of Hope

The Tug-of-War Over Abortion Pill Access: New York Fights Back Against Texas Ruling

The Game Changer? America's FDA Just Gave the Nod to an Oral Weight Loss Drug, But What's the Catch?

A Bittersweet Wait: Immuron's Travelan Data Faces an Unexpected Delay

The Heartbreaking Maze: Why Medicare Must Rethink Its Stance on Alzheimer's Treatment

Unlocking Access: The FDA's Bold Move to Fast-Track Life-Saving Biosimilars

A New Dawn for Menopause Relief: The Non-Hormonal Breakthrough That Could Change Everything

A New Dawn: Reclaiming Comfort from Menopause's Fiery Grip

Turning the Tide on Menopause: A Groundbreaking Hormone-Free Treatment Arrives

A Fresh Start for Relief: The FDA Greenlights Another Non-Hormonal Option for Menopause's Hottest Moments

The Heat is On... And Now, Perhaps, Off? A New FDA Approval for Menopause Relief

A New Dawn of Relief: Tackling Menopause Hot Flashes with a Fresh Approach

The Weekend's Big Buzz: Why Syndax Pharmaceuticals Just Shot for the Stars

A New Dawn for Bladder Cancer Patients: Astellas & Pfizer's Combination Therapy Halves Mortality Risk

FDA Approves Tezspire Self-Administration, Revolutionizing Severe Asthma Care for Amgen and AstraZeneca

Trump's Bold Pledge: Revolutionizing IVF Access with Drug Discounts and Expanded Fertility Benefits

Trump's Bold Initiative: Making IVF Affordable and Accessible for American Families

FDA Greenlights Groundbreaking Blood Test for Alzheimer's Disease

A New Era for Alzheimer's Diagnosis: FDA Approves First Blood Test

A New Dawn for Diagnostics: FDA Approves First Blood Test for Alzheimer's Disease

A New Dawn for Alzheimer's Diagnosis: FDA Approves Roche and Eli Lilly's Groundbreaking Blood Test

Healthcare Giants Soar: Novo Nordisk, Bristol Myers Squibb, and J&J Lead the Week's Breakthroughs

A New Dawn for Bladder Control: Medtronic's Altaviva and BlueWind's Revi Promise Life-Changing Freedom

Game-Changer for Seniors: IceCure's ProSense Revolutionizes Breast Cancer Treatment for Women Over 70

Lupin Unleashes Affordable Overactive Bladder Treatment in the U.S. Market

Unpacking the Market's Pulse: From Pharma Politics to Robotic Deliveries and the Fed's Inflation Fight

Rezdiffra's Global Ascendancy: Madrigal Pharmaceuticals Reshaping NASH Treatment

Amneal Pharmaceuticals Eyes Major Market Entry with Xolair Biosimilar, Pledging Affordable Relief

Regeneron's Evkeeza Achieves Landmark FDA Approval, Extending Life-Saving Treatment to Youngest HoFH Patients

Crinetics' Game-Changing Oral Therapy, Palsonify, Secures FDA Approval for Acromegaly

FDA Greenlights Leucovorin for Cancer Support Amidst Unrelated Autism Treatment Buzz

A New Horizon for Duchenne: FDA Approves First Gene Therapy for Life-Threatening Disease in Boys

Your Essential Guide to Getting the Updated COVID-19 Vaccine: What You Need to Know About Coverage and Access

Neuralink's Ambitious Leap: Human Trials for Thought-to-Text Technology Set for October